1-Methylamino-1-(3,4-methylenedioxyphenyl)propane

1-Methylamino-1-(3,4-methylenedioxyphenyl)propane
Clinical data
Other names3,4-Methylenedioxy-α-ethyl-N-methylbenzylamine; α-Ethyl-N-methylpiperonylamine; 1-Methylamino-1-(3,4-methylenedioxyphenyl)propane
Routes of
administration		Oral[1]
Drug classUnknown[1]
ATC code
  • None
Pharmacokinetic data
Duration of action~6 hours[1]
Identifiers
  • 1-(1,3-Benzodioxol-5-yl)-N-methylpropan-1-amine
CAS Number
PubChem CID
ChemSpider
UNII
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC11H15NO2
Molar mass193.246 g·mol−1
3D model (JSmol)
  • CNC(CC)C1=CC2=C(C=C1)OCO2
  • InChI=1S/C11H15NO2/c1-3-9(12-2)8-4-5-10-11(6-8)14-7-13-10/h4-6,9,12H,3,7H2,1-2H3 ☒N
  • Key:NLINVDHEDVEOMJ-UHFFFAOYSA-N ☒N
  (verify)

M-ALPHA, also known as 3,4-methylenedioxy-α-ethyl-N-methylbenzylamine or as α-ethyl-N-methylpiperonylamine, is a psychoactive drug of the substituted benzylamine group.[1][2] It was reported by Alexander Shulgin in his book PIHKAL as a positional isomer of MDMA.[1][2] Subsequently, the drug was encountered as a designer drug in the United Kingdom in 2010 and was reported to the EMCDDA new drug monitoring service.[3] It was described by Shulgin as similar in action to its demethylated homologue, ALPHA, but with roughly twice the duration and twice the potency.[1] ALPHA itself was described as active at doses of 10 to 140 mg, with a duration of about 3 hours, and producing eyes-closed "dreams", some body tingling, and a pleasant positive feeling, but without any appetite suppression.[1] M-ALPHA was encountered as a designer drug by 2010.[4]

See also

References

  1. ^ a b c d e f g Shulgin A, Shulgin A (September 1991). PiHKAL: A Chemical Love Story. Berkeley, California: Transform Press. ISBN 0-9630096-0-5. OCLC 25627628.
  2. ^ a b Shulgin A, Manning T, Daley PF (2011). The Shulgin Index, Volume One: Psychedelic Phenethylamines and Related Compounds. Vol. 1. Berkeley: Transform Press. ISBN 978-0-9630096-3-0.
  3. ^ "EMCDDA Annual Report 2010" (PDF). Archived from the original (PDF) on 2012-03-14. Retrieved 2011-10-10.
  4. ^ "EMCDDA–Europol 2010 Annual Report on the implementation of Council Decision 2005/387/JHA". www.euda.europa.eu. 2 July 2024. Retrieved 9 April 2025.


This article is issued from Wikipedia. The text is available under Creative Commons Attribution-Share Alike 4.0 unless otherwise noted. Additional terms may apply for the media files.